{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:05:40Z","timestamp":1771002340060,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030873","name":"Erasmus MC Kanker Instituut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001831","name":"Technische Universiteit Delft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.breast.2026.104698","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:28:56Z","timestamp":1768202936000},"page":"104698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Guiding treatment decisions in early breast cancer: A model-based comparison of the OncotypeDX and MammaPrint tests"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9882-0941","authenticated-orcid":false,"given":"Frank","family":"Doornkamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth C.","family":"de Wreede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfi","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewout W.","family":"Steyerberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2026.104698_bib1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2001.19.4.980","article-title":"Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer","author":"Ravdin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-017-0852-3","article-title":"An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation","volume":"19","author":"Candido dos Reis","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2026.104698_bib3","first-page":"R1","volume":"12","author":"Wishart","year":"2010","journal-title":"Predict\u202f: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res"},{"key":"10.1016\/j.breast.2026.104698_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejca.2022.06.011","article-title":"Incorporating progesterone receptor expression into the PREDICT breast prognostic model","volume":"173","author":"Grootes","year":"2022","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.breast.2026.104698_bib5","first-page":"545","article-title":"Better together: clinical and genomic data to inform shared decision making","volume":"39","author":"Crew","year":"2021","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.breast.2026.104698_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13058-015-0514-2","article-title":"Multigene prognostic tests in breast cancer: past, present, future","volume":"17","author":"Gy\u0151rffy","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2026.104698_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ctrv.2017.10.012","article-title":"Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe","volume":"62","author":"Blok","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2026.104698_bib8","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.3390\/ijms25115717","article-title":"The evolving role of genomic testing in early breast cancer: implications for diagnosis, prognosis, and therapy","volume":"25","author":"Venetis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.breast.2026.104698_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2026.104698_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(21)00007-3","article-title":"70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age","volume":"22","author":"Piccart","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-Gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2026.104698_bib12","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.22.00069","article-title":"Biomarkers for adjuvant endocrine and chemotherapy in early-stage Breast Cancer: ASCO Guideline update","volume":"40","author":"Andre","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","article-title":"Understanding breast cancer complexity to improve patient outcomes: the St Gallen International Consensus Conference for the Primary Therapy of Individuals with early Breast Cancer 2023","volume":"34","author":"Curigliano","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw050","article-title":"Comparing breast cancer multiparameter tests in the OPTIMA prelim trial: no Test is more equal than the others","volume":"108","author":"Bartlett","year":"2016","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2026.104698_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13058-023-01612-9","article-title":"Evaluation and comparison of different breast cancer prognosis scores based on gene expression data","volume":"25","author":"Chowdhury","year":"2023","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2026.104698_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ijc.32139","article-title":"Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score\u00ae (RS) assay and other genomic assays for early breast cancer","volume":"145","author":"Varga","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2026.104698_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23300","article-title":"Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis","volume":"23","author":"Harnan","year":"2019","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.breast.2026.104698_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis research strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.breast.2026.104698_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jclinepi.2011.07.003","article-title":"A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare","volume":"65","author":"Ferrante di Ruffano","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.breast.2026.104698_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jval.2017.01.001","article-title":"Systematic review of health economic impact evaluations of risk prediction models: stop developing, start evaluating","volume":"20","author":"van Giessen","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.breast.2026.104698_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1373\/clinchem.2012.182576","article-title":"Beyond diagnostic accuracy: the clinical utility of diagnostic tests","volume":"58","author":"Bossuyt","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.breast.2026.104698_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jclinepi.2019.07.010","article-title":"Decision analytic modeling was useful to assess the impact of a prediction model on health outcomes before a randomized trial","volume":"115","author":"Jenniskens","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.breast.2026.104698_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0272989X21991173","article-title":"Personalized decision making on genomic testing in early breast cancer: expanding the MINDACT trial with decision-analytic modeling","volume":"41","author":"Steyerberg","year":"2021","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.breast.2026.104698_bib25","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2026.104698_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-Gene recurrence Score assay in a randomized trial of chemotherapy for postmenopausal, Node-Positive, Estrogen receptor-positive breast cancer","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib27","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer","volume":"24","author":"Paik","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2026.104698_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","article-title":"Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials","volume":"401","author":"Braybrooke","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2026.104698_bib29","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1904819","article-title":"Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer","volume":"380","author":"Sparano","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2026.104698_bib30","series-title":"Decision making in health and medicine: integrating evidence and values","author":"Hunink","year":"2014"},{"key":"10.1016\/j.breast.2026.104698_bib31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ctrv.2014.06.007","article-title":"Patients' preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review","volume":"40","author":"Hamelinck","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2026.104698_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-6215-8-14","article-title":"Method for evaluating prediction models that apply the results of randomized trials to individual patients","volume":"8","author":"Vickers","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.breast.2026.104698_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.breast.2026.104698_bib34","series-title":"R: a Language and environment for statistical computing","year":"2022"},{"key":"10.1016\/j.breast.2026.104698_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00001648-199905000-00015","article-title":"Redundancy of single diagnostic Test evaluation","volume":"10","author":"Moons","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.breast.2026.104698_bib36","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2026.104698_bib37","first-page":"1335","article-title":"Outcome of patients with an ultralow-risk 70-Gene signature in the MINDACT trial","volume":"40","author":"Lopes Cardozo","year":"2022","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.breast.2026.104698_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.breast.2026.104698_bib39","article-title":"Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project","volume":"18","author":"Rietjens","year":"2024","journal-title":"Palliat Care Soc Pract"},{"key":"10.1016\/j.breast.2026.104698_bib40","unstructured":"Predict Breast side effects n.d. https:\/\/side-effects.breast.predict.cam\/(accessed November 8, 2024)."}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:09:05Z","timestamp":1770998945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S0960977626000081"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104698","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guiding treatment decisions in early breast cancer: A model-based comparison of the OncotypeDX and MammaPrint tests","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104698"}}